Prasanna Ponugoti1, Jingmei Lin2, Robert Odze3, Dale Snover4, Charles Kahi1, Douglas K Rex1. 1. Division of Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. 2. Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA. 3. Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA. 4. Department of Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND AND AIMS: The American Society for Gastrointestinal Endoscopy recommends that distal colon hyperplastic lesions can be left in place without resection if adenomatous histology can be excluded with >90% negative predictive value. However, some lesions could be sessile serrated adenomas/polyps (SSA/Ps), which is also precancerous. The aim of this study was to describe the prevalence of SSA/Ps in hyperplastic-appearing diminutive rectosigmoid polyps. METHODS: We prospectively placed 513 consecutive diminutive rectosigmoid polyps that appeared hyperplastic to an expert endoscopist in individual bottles for pathologic. Each polyp was examined by 3 expert GI pathologists. RESULTS: The prevalence of SSA/P in the study polyps ranged from .6% to 2.1%. The lowest negative predictive value found by the endoscopist for the combination of adenomas plus SSA/Ps was 96.7%. CONCLUSIONS: The prevalence of SSA/Ps in diminutive rectosigmoid hyperplastic-appearing polyps is very low. These results support the safety and feasibility of a "do not resect" policy for diminutive hyperplastic-appearing rectosigmoid polyps.
BACKGROUND AND AIMS: The American Society for Gastrointestinal Endoscopy recommends that distal colon hyperplastic lesions can be left in place without resection if adenomatous histology can be excluded with >90% negative predictive value. However, some lesions could be sessile serrated adenomas/polyps (SSA/Ps), which is also precancerous. The aim of this study was to describe the prevalence of SSA/Ps in hyperplastic-appearing diminutive rectosigmoid polyps. METHODS: We prospectively placed 513 consecutive diminutive rectosigmoid polyps that appeared hyperplastic to an expert endoscopist in individual bottles for pathologic. Each polyp was examined by 3 expert GI pathologists. RESULTS: The prevalence of SSA/P in the study polyps ranged from .6% to 2.1%. The lowest negative predictive value found by the endoscopist for the combination of adenomas plus SSA/Ps was 96.7%. CONCLUSIONS: The prevalence of SSA/Ps in diminutive rectosigmoid hyperplastic-appearing polyps is very low. These results support the safety and feasibility of a "do not resect" policy for diminutive hyperplastic-appearing rectosigmoid polyps.
Authors: Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson Journal: Am J Gastroenterol Date: 2017-06-06 Impact factor: 10.864
Authors: Rebecca A Gourevitch; Sherri Rose; Seth D Crockett; Michele Morris; David S Carrell; Julia B Greer; Reetesh K Pai; Robert E Schoen; Ateev Mehrotra Journal: Am J Gastroenterol Date: 2018-01-30 Impact factor: 10.864
Authors: Priscilla S P Oliveira; Rita B Carvalho; Daniela O Magro; Michel G Camargo; Carlos A R Martinez; Claudio S R Coy Journal: Gastroenterol Res Pract Date: 2018-10-21 Impact factor: 2.260
Authors: Andreas W Berger; Katja Raedler; Cord Langner; Leopold Ludwig; Nektarios Dikopoulos; Karl F Becker; Julia Slotta-Huspenina; Michael Quante; Daniel Schwerdel; Lukas Perkhofer; Alexander Kleger; Eugen Zizer; Franz Oswald; Thomas Seufferlein; Alexander Meining Journal: United European Gastroenterol J Date: 2017-07-28 Impact factor: 4.623